search
Back to results

ExPECT: Extraperitoneal End Colostomy Trial (ExPECT)

Primary Purpose

Colostomy Stoma, Cancer of Colon, Surgery

Status
Recruiting
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Extra-peritoneal
Sponsored by
Swansea Bay University Health Board
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Colostomy Stoma focused on measuring colostomy, surgery, colon cancer, feasibility study, cancer

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Aged 18 years and over
  • Able and willing to give informed consent to participate
  • Elective patient for colorectal surgery requiring formation of permanent end colostomy (This may include patients undergoing surgery for rectal or anal cancer, inflammatory bowel disease, diverticular disease and functional bowel disorders)
  • Suitable to receive both trans-peritoneal and extra-peritoneal techniques

Exclusion Criteria:

  • Lacking the capacity to consent
  • Having emergency surgery
  • Previous or current abdominal wall stoma
  • Intention to form loop colostomy, ileostomy or double-barrelled stoma
  • Previous incisional hernia repair with disruption of abdominal wall layers
  • Pregnant or breastfeeding (as determined by standard NHS procedures)

Sites / Locations

  • Cardiff and Vale University Health BoardRecruiting
  • Aneurin Bevan University Health BoardRecruiting
  • Swansea Bay University Health BoardRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Trans-peritoneal

Extra-peritoneal

Arm Description

Surgery technique in the formation of permanent end colostomy

Surgery technique in the formation of permanent end colostomy

Outcomes

Primary Outcome Measures

Patient-reported EQ5D
Quality of life measure
Patient-reported EQ5D
Quality of life measure
Patient-reported EQ5D
Quality of life measure
Patient-reported EQ5D
Quality of life measure
Patient-reported Colostomy Impact Score
Quality of life measure. A scoring system is in place for this measure - 0-9 indicates a minor colostomy impact, 10-38 indicates a major colostomy impact.
Patient-reported Colostomy Impact Score
Quality of life measure. A scoring system is in place for this measure - 0-9 indicates a minor colostomy impact, 10-38 indicates a major colostomy impact.
Patient-reported Colostomy Impact Score
Quality of life measure. A scoring system is in place for this measure - 0-9 indicates a minor colostomy impact, 10-38 indicates a major colostomy impact.
Rate of parastomal hernia
Quantitative frequency of hernia formation
Rate of parastomal hernia
Quantitative frequency of hernia formation.
Rate of parastomal hernia
Quantitative frequency of hernia formation
Rate of AE/SAE related to intervention procedure
Safety data

Secondary Outcome Measures

Full Information

First Posted
November 8, 2021
Last Updated
January 30, 2023
Sponsor
Swansea Bay University Health Board
Collaborators
Swansea University
search

1. Study Identification

Unique Protocol Identification Number
NCT05163873
Brief Title
ExPECT: Extraperitoneal End Colostomy Trial
Acronym
ExPECT
Official Title
ExPECT: Extraperitoneal End Colostomy Trial - Feasibility Phase
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 9, 2021 (Actual)
Primary Completion Date
October 2023 (Anticipated)
Study Completion Date
October 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Swansea Bay University Health Board
Collaborators
Swansea University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
A randomised controlled feasibility study to compare two surgery techniques in the formation of a permanent end colostomy; the trans-peritoneal(TP) technique - currently, the most commonly used technique and the investigational extra-peritoneal(EP) technique, which has been reported in small studies to reduce the risk of parastomal hernia . This feasibility study will primarily aim to determine the feasibility viability of progression to a full multi-centre trial and test study design acceptability for participants. Participants will be asked to consent to be randomised to either the TP or EP procedure during surgery. Following surgery, participants will be followed up to a maximum of 12 months and asked to complete quality of life questionnaires (EQ5D and Colostomy Impact Score). Participant data will also be accessed by research teams at site to collect data on stoma appliance use and complications.
Detailed Description
This feasibility study is a multi-centre, single (patient) blinded, randomised controlled trial (RCT). Co-ordination and trial management will be led from Swansea Trials Unit (STU) and we will adhere to their Standard Operating Procedures (SOPs). The study will take place across 3 sites: Swansea Bay University Health Board (SBUHB); Aneurin Bevan University Health Board and Cardiff and Vale University Health Board. Surgeons at all three sites have experience with both interventional extra-peritoneal surgical technique and the most commonly used transperitoneal technique. The investigators aim to recruit 60 participants over 12 months. Local recruitment will be co-ordinated by PIs and research teams. Recruitment is aimed to be equally distributed across all sites. Participants will be equally randomised by arm in each of the three sites: to receive the EP colostomy formation (Intervention) or the standard transperitoneal (TP) technique. Participants will remain blinded as to their treatment until the close of the study. Data collection will be performed by the Welsh Barbers trainee collaborative and the clinical and research teams, with support from PIs. Data will be stored centrally in REDCap (Research Electronic Data Capture) software. The investigators will explore whether it is possible to establish a research infrastructure in which data can be collected and co-ordinated across sites and for patients to be followed up effectively. The investigators will also look to demonstrate standardisation of the operative technique for EP stoma formation and to determine which outcome measures a future trial should explore. This feasibility trial be evaluated against specific progression criteria.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colostomy Stoma, Cancer of Colon, Surgery, Quality of Life
Keywords
colostomy, surgery, colon cancer, feasibility study, cancer

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Trans-peritoneal
Arm Type
No Intervention
Arm Description
Surgery technique in the formation of permanent end colostomy
Arm Title
Extra-peritoneal
Arm Type
Experimental
Arm Description
Surgery technique in the formation of permanent end colostomy
Intervention Type
Procedure
Intervention Name(s)
Extra-peritoneal
Intervention Description
Surgery procedure: a non-mesh prophylactic surgical technique to prevent PH
Primary Outcome Measure Information:
Title
Patient-reported EQ5D
Description
Quality of life measure
Time Frame
1 day (At time of consent)
Title
Patient-reported EQ5D
Description
Quality of life measure
Time Frame
Week 6
Title
Patient-reported EQ5D
Description
Quality of life measure
Time Frame
Week 26
Title
Patient-reported EQ5D
Description
Quality of life measure
Time Frame
Week 52
Title
Patient-reported Colostomy Impact Score
Description
Quality of life measure. A scoring system is in place for this measure - 0-9 indicates a minor colostomy impact, 10-38 indicates a major colostomy impact.
Time Frame
Week 6
Title
Patient-reported Colostomy Impact Score
Description
Quality of life measure. A scoring system is in place for this measure - 0-9 indicates a minor colostomy impact, 10-38 indicates a major colostomy impact.
Time Frame
Week 26
Title
Patient-reported Colostomy Impact Score
Description
Quality of life measure. A scoring system is in place for this measure - 0-9 indicates a minor colostomy impact, 10-38 indicates a major colostomy impact.
Time Frame
Week 52
Title
Rate of parastomal hernia
Description
Quantitative frequency of hernia formation
Time Frame
Week 6
Title
Rate of parastomal hernia
Description
Quantitative frequency of hernia formation.
Time Frame
Week 26
Title
Rate of parastomal hernia
Description
Quantitative frequency of hernia formation
Time Frame
Week 52
Title
Rate of AE/SAE related to intervention procedure
Description
Safety data
Time Frame
30 days post-surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Aged 18 years and over Able and willing to give informed consent to participate Elective patient for colorectal surgery requiring formation of permanent end colostomy (This may include patients undergoing surgery for rectal or anal cancer, inflammatory bowel disease, diverticular disease and functional bowel disorders) Suitable to receive both trans-peritoneal and extra-peritoneal techniques Exclusion Criteria: Lacking the capacity to consent Having emergency surgery Previous or current abdominal wall stoma Intention to form loop colostomy, ileostomy or double-barrelled stoma Previous incisional hernia repair with disruption of abdominal wall layers Pregnant or breastfeeding (as determined by standard NHS procedures)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kirsty J Lanyon, BSc
Phone
01792604295
Email
k.j.lanyon@swansea.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
Kym Carter, PhD
Email
k.carter@swansea.ac.uk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gregory Taylor
Organizational Affiliation
Swansea Bay University Health Board
Official's Role
Study Director
Facility Information:
Facility Name
Cardiff and Vale University Health Board
City
Cardiff
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Catrin Truan
Email
catrin.truan@wales.nhs.uk
First Name & Middle Initial & Last Name & Degree
Alun Meggy
Phone
02921 846124
Email
Alun.Meggy@wales.nhs.uk
First Name & Middle Initial & Last Name & Degree
Jared Torkington
Facility Name
Aneurin Bevan University Health Board
City
Newport
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anna Pennington
Phone
01633 656353
Email
Anna.pennington@wales.nhs.uk
First Name & Middle Initial & Last Name & Degree
Nancy Hawkins
Phone
01633 238967
Email
nancy.hawkings@wales.nhs.uk
First Name & Middle Initial & Last Name & Degree
Gethin Williams
Facility Name
Swansea Bay University Health Board
City
Swansea
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anne-Claire Owen
Email
Anne-Claire.Owen@wales.nhs.uk
First Name & Middle Initial & Last Name & Degree
Elaine Brinkworth
Email
Elaine.Brinkworth@wales.nhs.uk
First Name & Middle Initial & Last Name & Degree
Dean Harries

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
No current plan to share IPD but will discuss with study team if and/or when the request arises.

Learn more about this trial

ExPECT: Extraperitoneal End Colostomy Trial

We'll reach out to this number within 24 hrs